Dr. Andrew Cowan, MD
Claim this profileFred Hutch/University of Washington Cancer Consortium
Studies Multiple Myeloma
Studies Chronic Lymphocytic Leukemia
9 reported clinical trials
14 drugs studied
Area of expertise
1Multiple Myeloma
Stage IV
Stage III
2Chronic Lymphocytic Leukemia
Affiliated Hospitals
Clinical Trials Andrew Cowan, MD is currently running
Mezigdomide Combo vs. Pomalidomide Combo
for Multiple Myeloma
This trial is testing two drug combinations to find out which one is better and safer for patients with multiple myeloma that has come back or not responded to previous treatments. The drugs work together to kill cancer cells by stopping their growth, helping the immune system attack them, and making it harder for them to survive.
Recruiting2 awards Phase 3
Lenalidomide + Dexamethasone +/- Daratumumab
for Multiple Myeloma
This phase III trial studies how well lenalidomide and dexamethasone works with or without daratumumab in treating patients with high-risk smoldering myeloma. Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells to grow and spread. Giving lenalidomide and dexamethasone with daratumumab may work better in treating patients with smoldering myeloma.
Recruiting2 awards Phase 312 criteria
More about Andrew Cowan, MD
Clinical Trial Related4 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Andrew Cowan, MD has experience with
- Dexamethasone
- Pomalidomide
- Lenalidomide
- CC-92480
- Bortezomib
- Exosome Testing
Breakdown of trials Andrew Cowan, MD has run
Multiple Myeloma
Chronic Lymphocytic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew Cowan, MD specialize in?
Andrew Cowan, MD focuses on Multiple Myeloma and Chronic Lymphocytic Leukemia. In particular, much of their work with Multiple Myeloma has involved Stage IV patients, or patients who are Stage III.
Is Andrew Cowan, MD currently recruiting for clinical trials?
Yes, Andrew Cowan, MD is currently recruiting for 2 clinical trials in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Andrew Cowan, MD has studied deeply?
Yes, Andrew Cowan, MD has studied treatments such as Dexamethasone, Pomalidomide, Lenalidomide.
What is the best way to schedule an appointment with Andrew Cowan, MD?
Apply for one of the trials that Andrew Cowan, MD is conducting.
What is the office address of Andrew Cowan, MD?
The office of Andrew Cowan, MD is located at: Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington 98109 United States. This is the address for their practice at the Fred Hutch/University of Washington Cancer Consortium.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.